CHGX
AXS Change Finance ESG ETF
CHGX tracks an index of 100 US large-cap stocks that meet diverse environmental, social, and governance standards.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 176.4 M
ASSETS UNDER MGMT
49 bp
EXPENSES
Fund Basics
| Inception date | Oct 09, 2017 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| ADVANCED MICRO DEVICES | 1.2 % |
| INTEL CORP | 1.2 % |
| ROCKET LAB CORP | 1.2 % |
| TWILIO, INC. CLASS A | 1.2 % |
| MARVELL TECHNOLOGY, INC. | 1.1 % |
| MONOLITHIC POWER SYSTEMS INC | 1.1 % |
| CADENCE DESIGN SYS INC | 1.1 % |
| INTUITIVE SURGICAL INC | 1.1 % |
| CLOUDFLARE INC CLASS A | 1.1 % |
| THERMO FISHER SCIENTIFIC INC | 1.1 % |
Constituent Breakdown
| Number of holdings | 100 |
| Herfindahl-Hirschman Index | 102 |
| Wgt avg mkt cap (mns) | $241,208 |
| Large cap (>$10bn) | 95.9% |
| Mid cap ($2-10bn) | 3.6% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 99.6% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 94.0 % |
 |
IRELAND | 3.8 % |
 |
SINGAPORE | 1.0 % |
 |
AUSTRALIA | 1.0 % |
Historical Performance
Standardized Performance (as of 08/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 24.4% | 26.8% | 17.7% | 18.8% | 8.7% | -- | -- | 12.8% |
| Dividend Yield | 0.0% | 0.9% | 0.9% | 1.0% | 0.9% | -- | -- | 1.0% |
| Total Returns | 24.4% | 27.6% | 18.7% | 19.8% | 9.6% | -- | -- | 13.8% | Ann. Volatility | 16.2% | 15.1% | 16.7% | 15.5% | 35.6% | -- | -- | 39.2% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.05 | 78% |
| MSCI EAFE | 0.71 | 54% |
| MSCI Emg Mkts | 0.45 | 53% |
Liquidity Measures
| Avg. volume (000) | 26 |
| ADV traded (mns) | $1 |
| Turnover | 0.5% |
| Avg. Bid/Ask (% of price) | 0.04% |
Technical Indicators
| 30d moving avg. (EMA) | $32.98 |
| Relative strength (RSI) | 64 |
| MACD/Signal | 0.40/0.25 |
| Bollinger Bands (Upper/Lower) | $34.34/$31.43 |
| Short interest (% of AUM) | 0.2% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. CHGX |
Expenses vs. CHGX |
ALTAR Score™ vs. CHGX |
|---|---|---|---|---|
| ESMV | iShares ESG MSCI USA Min Vol Factor ETF | 34.7% | -31 bp | +1.0% |
| USMV | iShares MSCI USA Min Vol Factor ETF | 33.6% | -34 bp | +1.3% |
| EQWL | Invesco S&P 100 Equal Weight ETF | 31.7% | -24 bp | +1.0% |
| USXF | iShares ESG Advanced MSCI USA ETF | 31.3% | -39 bp | -0.3% |
| VEGN | US Vegan Climate ETF | 29.8% | +11 bp | -0.8% |
| ROE | Astoria US Quality Kings ETF | 29.8% | 0 bp | +1.8% |
| XMAG | Defiance Large Cap ex-Mag 7 ETF | 29.8% | -14 bp | -0.1% |
| SUSA | iShares MSCI USA ESG Select ETF | 29.7% | -24 bp | -0.2% |
| PQUS | Pictet AI Enhanced US Equity ETF | 29.5% | -27 bp | -0.2% |
| LVDS | JPMorgan Fundamental Data Science Large Value ETF | 29.1% | 0 bp | +0.5% |
Risk and Returns: CHGX vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 9/29/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
5.0%
ALTAR SCORE™
41st
PERCENTILE
NEUTRAL
ETFRC RATING
There are 1,398 funds in the US Equity category with an average
ALTAR Score™ of 5.4% and a standard deviation
of 2.1%. CHGX's ALTAR Score™ is approximately -0.2 standard
deviations above the category average. This places CHGX in the 41st percentile
among funds in the category.
Sell-Side Consensus
$37.05
PRICE TARGET
+12.2%
UPSIDE